| __timestamp | Alnylam Pharmaceuticals, Inc. | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 26551000 |
| Thursday, January 1, 2015 | 41097000 | 50286000 |
| Friday, January 1, 2016 | 47159000 | 81321000 |
| Sunday, January 1, 2017 | 89912000 | 159201000 |
| Monday, January 1, 2018 | 74908000 | 251247000 |
| Tuesday, January 1, 2019 | 219750000 | 306486000 |
| Wednesday, January 1, 2020 | 492853000 | 353874000 |
| Friday, January 1, 2021 | 844287000 | 365978000 |
| Saturday, January 1, 2022 | 1037418000 | 401858000 |
| Sunday, January 1, 2023 | 1828292000 | 482375000 |
| Monday, January 1, 2024 | 2248243000 |
Infusing magic into the data realm
In the competitive landscape of biotechnology, Alnylam Pharmaceuticals and Corcept Therapeutics have shown remarkable revenue trajectories over the past decade. Alnylam, known for its innovative RNA interference therapies, has seen its revenue skyrocket by over 3,500% from 2014 to 2023. This growth is a testament to its successful product launches and expanding market presence. In contrast, Corcept Therapeutics, specializing in treatments for metabolic disorders, has experienced a steady revenue increase of approximately 1,700% during the same period. While Alnylam's revenue surged to nearly four times that of Corcept by 2023, both companies have demonstrated resilience and adaptability in a rapidly evolving industry. This revenue showdown highlights the dynamic nature of the biotech sector, where innovation and strategic market positioning are key to financial success.
Revenue Insights: Eli Lilly and Company and Corcept Therapeutics Incorporated Performance Compared
Who Generates More Revenue? Takeda Pharmaceutical Company Limited or Alnylam Pharmaceuticals, Inc.
Annual Revenue Comparison: Takeda Pharmaceutical Company Limited vs Corcept Therapeutics Incorporated
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or Teva Pharmaceutical Industries Limited?
Annual Revenue Comparison: Alnylam Pharmaceuticals, Inc. vs Catalent, Inc.
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc.?
Comparing Revenue Performance: Alnylam Pharmaceuticals, Inc. or MiMedx Group, Inc.?
Revenue Showdown: Viatris Inc. vs Corcept Therapeutics Incorporated
Revenue Insights: Catalent, Inc. and Corcept Therapeutics Incorporated Performance Compared
Comparing Revenue Performance: Corcept Therapeutics Incorporated or Geron Corporation?
Corcept Therapeutics Incorporated or Galapagos NV: Who Leads in Yearly Revenue?
Corcept Therapeutics Incorporated vs Celldex Therapeutics, Inc.: Examining Key Revenue Metrics